| |
|
- Casau NC, Glesby MJ, Gulick
RM. Concurrent use
of lopinavir/ritonavir and a third protease-inhibitor in treatment-experienced
HIV infected patients. . JAIDS (In press)
- Paul S,
Bogdanov MB, Matson WR, Metakis L, Jacobs J, Beal MF. Urinary
8'-2'-deoxyguanosine, a metabolite of oxidized DNA, is not elevated in
HIV Patients on combination antiretroviral therapy. Free Radical Research.
(In press)
- Paul S, Gilbert
HM, Lande L, Vaamonde CV, Jacobs J, Malak
S, Sepkowitz KA. Impact of antiretroviral therapy on
decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Research and Human Retroviruses 2002, 18(7):501-506.
- Paul, S. Prioritization
of medical problems to improve adherence. Clinical Pharmacology
and Therapeutics 2002 71(4):211-213.
- Paul S, Gilbert
HM, Ziecheck W.,Jacobs J, Sepkowitz KA. The impact of
potent antiretroviral therapy on the characteristics of
hospitalized patients with human immunodeficiency virus infection. AIDS 1999, 13:415-418.
- Gomes MS, Paul
S, Moreira AL. Appelberg R, Rabinovitch M, Kaplan G. Survival of
Mycobacterium avium intracellulare and Mycobacterium tuberculosis
in acidified vacuoles of murine macrophages. Infection and
Immunity 1999, 67(7):3199-3206.
|
